Predictors of subclinical carotid atherosclerosis in middle-aged women (2018)
- Authors:
- Autor USP: NICOLAU, JOSÉ CARLOS - FM
- Unidade: FM
- DOI: 10.1371/journal.pone.0197582
- Subjects: ARTÉRIA CARÓTIDA EXTERNA; DOENÇAS CARDIOVASCULARES; ARTERIOSCLEROSE; MORTALIDADE
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Publisher place: San Francisco
- Date published: 2018
- Source:
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
BARROS, Isly L. de e NICOLAU, Jose C. Predictors of subclinical carotid atherosclerosis in middle-aged women. PLOS ONE, v. 13, n. 5, 2018Tradução . . Disponível em: https://doi.org/10.1371/journal.pone.0197582. Acesso em: 18 set. 2024. -
APA
Barros, I. L. de, & Nicolau, J. C. (2018). Predictors of subclinical carotid atherosclerosis in middle-aged women. PLOS ONE, 13( 5). doi:10.1371/journal.pone.0197582 -
NLM
Barros IL de, Nicolau JC. Predictors of subclinical carotid atherosclerosis in middle-aged women [Internet]. PLOS ONE. 2018 ; 13( 5):[citado 2024 set. 18 ] Available from: https://doi.org/10.1371/journal.pone.0197582 -
Vancouver
Barros IL de, Nicolau JC. Predictors of subclinical carotid atherosclerosis in middle-aged women [Internet]. PLOS ONE. 2018 ; 13( 5):[citado 2024 set. 18 ] Available from: https://doi.org/10.1371/journal.pone.0197582 - Ticagrelor versus clopidogrel in patients with STEMI treated with fibrinolysis TREAT trial
- Ticagrelor vs Clopidogrel After Fibrinolytic Therapy in Patients With ST-Elevation Myocardial Infarction: A Randomized Clinical Trial (vol 3, pg 391, 2018)
- Effects of Dapagliflozin on Symptoms, Function, and Quality of Life in Patients With Heart Failure and Reduced Ejection Fraction Results From the DAPA-HF Trial
- Efficacy and Safety of Dapagliflozin in Heart Failure With Reduced Ejection Fraction According to Age Insights From DAPA-HF
- Effect of alirocumab on mortality after acute coronary syndromes an analysis of the ODYSSEY OUTCOMES randomized clinical trial
- Predicting risk of cardiovascular events 1 to 3 years post-myocardial infarction using a global registry
- Long-term ticagrelor for secondary prevention in patients with prior myocardial infarction and no history of coronary stenting: insights from PEGASUS-TIMI 54
- Two-year outcomes among stable high-risk patients following acute MI. Insights from a global registry in 25 countries
- Anti-Thrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC): Study design and methodology for an international, adaptive Bayesian randomized controlled trial
- Rationale and design of the long-Term rIsk, clinical manaGement, and healthcare Resource utilization of stable coronary artery dISease in post-myocardial infarction patients (TIGRIS) study
Informações sobre o DOI: 10.1371/journal.pone.0197582 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas